Northwestern Medicine and Vitestro collaborate to advance autonomous robotic phlebotomy
Northwestern Medicine and Vitestro announced a multi-year collaboration to advance automation in phlebotomy and transform the patient experience.
As part of this collaboration, Northwestern Medicine will participate in a multicenter clinical trial validating the performance and safety of Vitestro’s Aletta—the world’s first Autonomous Robotic Phlebotomy Device (ARPD). The goal of the study is to generate key clinical evidence to support adoption of automated phlebotomy as a scalable solution for U.S. hospital and outpatient blood draw centers.
By automating and standardizing blood collection, this collaboration aims to:
• Address critical phlebotomy workforce shortages by providing a scalable, automated solution.
• Enhance operational efficiency and patient throughput in high-volume hospital outpatient settings.
• Improve sample quality and integrity, reducing errors associated with manual venipuncture
• Expand access to high-quality blood collection while enhancing patient comfort and overall care.
